3 options
Oral Anticoagulants: This animation will review the synthesis of vitamin K-dependent coagulation factors and illustrate how warfarin acts to inhibit the final step in the synthesis of these clotting factors / Donald K. Blumenthal, PhD, and Derek Cowan.
- Format:
- Video
- Author/Creator:
- Blumenthal, Donald K., author.
- Cowan, Derek, author.
- Series:
- McGraw-Hill's AccessAnesthesiology.
- McGraw-Hill's AccessHemOnc
- Language:
- English
- Subjects (All):
- Blood coagulation disorders--drug therapy.
- Blood coagulation disorders.
- Blood coagulation disorders--physiopathology.
- Cardiovascular system--Diseases--drug therapy.
- Cardiovascular system.
- Fibrinolytic agents--therapeutic use.
- Fibrinolytic agents.
- Physical Description:
- 1 online resource (1 video file, approximately 01 min. 07 sec.) : digital, .flv file, sound.
- Contained In:
- Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e New York, N.Y. : McGraw-Hill Education, 2017
- Other Title:
- Oral Anticoagulants
- Place of Publication:
- New York, N.Y. : McGraw-Hill Education LLC., 2017.
- Language Note:
- In English.
- System Details:
- digital
- video file MPEG-4 Flash
- Summary:
- The oral anticoagulant drug warfarin is widely used to prevent the formation of fibrin clots and emboli that can cause life-threatening myocardial infarctions, deep vein thromboses, pulmonary emboli, and thromboembolic strokes.
- Notes:
- Title from title frames.
- Originally produced by Donald K. Blumenthal and Derek Cowan in 2017.
- Description based on online resource; title from title screen (Internet Archive, viewed February 16, 2021)
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.